The decrease in expression of proinflammatory genes, such as IFN-related molecules and CLC, after starting the therapy in MPA patients with good response may simply indicate the individual strength of anti-inflammatory response to the treatment employed according to the protocols. Here, CLC is linked to microscopic polyangiitis.